8-K: 180 Life Sciences Corp. Announces Date for 2024 Annual Meeting of Shareholders

180 Life Sciences Corp. has set December 27, 2024, as the date for its 2024 Annual Meeting of Shareholders.

Summary

• 180 Life Sciences Corp. has scheduled its 2024 Annual Meeting of Shareholders for December 27, 2024.
• The company has set the shareholder record date for the meeting as October 31, 2024.
• Shareholders of record on this date will be eligible to vote at the Annual Meeting.
• The deadline for shareholder proposals to be included in the proxy materials is November 8, 2024.
• This deadline also applies to director nominations and other business proposals not made under Rule 14a-8.
• The company reserves the right to change both the meeting date and the record date.

Sentiment

Score: 7

Explanation: The document is a routine corporate announcement, providing necessary information for shareholders. It is neutral in tone and does not contain any significant positive or negative news.

Positives

• The announcement provides clarity on the timing of the Annual Meeting for shareholders.
• The company has clearly communicated the deadlines for shareholder proposals and director nominations.

Risks

• The company reserves the right to change the date of the Annual Meeting and the record date, which could cause uncertainty for shareholders.
• Failure to meet the deadlines for submitting proposals or nominations will result in them not being considered at the meeting.

Future Outlook

The company will release further details regarding the time and location of the Annual Meeting in its definitive proxy statement.

Management Comments

• The Board of Directors has determined the date for the 2024 Annual Meeting of Shareholders.
• The company reserves the right to change the date of the Annual Meeting prior thereto.

Industry Context

This announcement is a routine corporate event for publicly traded companies, ensuring shareholders are informed about the annual meeting and their rights to participate.

Comparison to Industry Standards

• The process of setting a record date and deadlines for shareholder proposals is standard practice for publicly listed companies.
• The timeline provided by 180 Life Sciences Corp. is consistent with typical corporate governance practices.

Stakeholder Impact

• Shareholders are informed about the upcoming Annual Meeting and their rights to participate.
• Shareholders are given deadlines for submitting proposals and nominations.

Next Steps

• The company will file a definitive proxy statement with the Securities and Exchange Commission.
• Shareholders should submit proposals and nominations by the November 8, 2024 deadline.
• Shareholders should monitor for updates regarding the time and location of the Annual Meeting.

Key Dates

Keywords

Annual Meeting, Shareholders, Proxy Statement, Director Nominations, Shareholder Proposals, Record Date, 180 Life Sciences Corp